Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
39 Most studies used B12 i.m., with slightly varying dosing regimens, commonly 1000 g daily for 57 days, followed by weekly injections for another 34 weeks, and then monthly injections
3 News-Medical / Metabolic pressCoverage of the AOD-9604 Phase 2b obesity trial outcome (development discontinued ~2007)
Inject into the lower abdominal fat at least 2 inches away from the navel, avoiding the midline
The most common additions target areas not covered by the KLOW blend
Findings out of the 3000 people tested, 39% presented borderline or slightly deficient, 17% presented low levels and 9% were considered clinically deficient
US$ 29.87
US$ 21.46
US$ 23.68
US$ 23.50
US$ 25.41
US$ 29.12
